Thomas A. Bologna is an experienced Chairman, President and Chief Executive Officer in leading public, venture and private equity backed diagnostic, pharmaceutical, device and clinical laboratory testing healthcare companies including turnarounds and start-ups, many of which he sold and/or took public. Mr. Bologna was Chairman of the Board and Chief Executive Officer of Response Genetics, Inc., a clinical laboratory company, President and Chief Executive Officer of Orchid Cellmark, Inc., a leading DNA testing services company with operations in the United States and Europe, President and Chief Executive Officer of Quorex Pharmaceuticals, Chairman of the Board, President and Chief Executive Officer of Ostex International, Inc., a company that developed and commercialized products for the therapeutic management of osteoporosis and Chairman of the Board, President and Chief Executive Officer of Gen-Probe, Incorporated, a highly successful molecular diagnostics company.
Mr. Bologna also held senior level positions of highly profitable healthcare divisions and subsidiaries of Fortune 500 companies including President of the Becton Dickinson Diagnostic Instrument Systems Division. He was also a founder and member of the Sponsoring Committee of the venture capital firm, Mission Ventures.
Mr. Bologna received his B.S. from the New York University School of Engineering and Science and his M.B.A. from the New York University Graduate School of Business Administration.